NICA — Nanologica AB (publ) Balance Sheet
0.000.00%
- SEK92.78m
- SEK71.67m
- SEK14.54m
Annual balance sheet for Nanologica AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 68 | 11.7 | 70.3 | 10.1 | 48.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.99 | 1.91 | 1.63 | 1.13 | 1.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 101 | 56.8 | 117 | 38.5 | 113 |
Net Property, Plant And Equipment | 31.4 | 27.3 | 21.7 | 15.8 | 14.4 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 146 | 98.3 | 155 | 77.4 | 143 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17.7 | 14.5 | 13.5 | 11.9 | 68.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 53.4 | 46.7 | 81.4 | 79.3 | 69 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 93 | 51.6 | 73.2 | -1.9 | 74.1 |
Total Liabilities & Shareholders' Equity | 146 | 98.3 | 155 | 77.4 | 143 |
Total Common Shares Outstanding |